How EHE Jurisdictions Can Increase Uptake of Long Acting Injectables for HIV Treatment
Resource updated 04/07/2023
Resource updated 04/07/2023
Resource (Conference Presentation) updated 09/14/2023
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 10/24/2023
Resource updated 05/11/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 01/19/2024
Resource updated 04/16/2024
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 04/03/2024
Resource updated 04/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023